The Use of MuGard™, Caphosol®, and Episil® in Patients Undergoing Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck

Journal of Radiotherapy in Practice - United Kingdom
doi 10.1017/s1460396913000472
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma

Ear, Nose and Throat Journal
MedicineOtorhinolaryngology
2019English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Elective Neck Dissection for Clinically N0 Neck in Squamous Cell Carcinoma of the Head and Neck

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
1996English

The Role of Computed Tomographic Scans in the Management of the N-Positive Neck in Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy

Archives of Otolaryngology–Head & Neck Surgery
2004English

Adjuvant Chemotherapy (Nedaplatin/Uft) After Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Journal of Otolaryngology of Japan
Otorhinolaryngology
2006English

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology–Head & Neck Surgery
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy